Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

NCT02249780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2016-04-18

No results posted yet for this study

Summary

Evaluate parathyroid gland perfusion during total thyroidectomy or thyroid totalisation surgery. Create an objective basis for the decision whether or not to transplant the parathyroid glands. Avoide postoperative serum calcium and parathyroid hormone dosages, and thus abstention of systematic supplementation with calcium and vitamin D in case of good perfusion.

Conditions

  • Parathyroid Function Low Adverse Event

Interventions

PROCEDURE

Postoperative parathyroid function test

Calcium and parathormone dosage at 24 hours and ten day after surgery

PROCEDURE

No postoperative parathyroid dosage and supplementation

The patients will be clinically followed for 24 hours after surgery and caclium and parathormone dosage will be done at ten days after surgery. No supplementation will be given.

PROCEDURE

ICG parathyroid angiography

Injection of 3,5 mL of indocyanine green intravenously and perform angiography of parathyroid glands after thyroid removal.

DRUG

Parathyroid supplementation

Supplementration with Calcimagon D3 Forte (1gr Calcium and 800 IU of 25-OH-vitamin D) from surgery day to up to 10 days afeter surgery.

Sponsors & Collaborators

  • Geneva University, School of medicine

    collaborator UNKNOWN
  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Frédéric Triponez, Professor · University Hospital, Geneva

  • Wolfram Karenovics, SPR · University Hospital, Geneva

  • Frédéric Ris, Consultant · University Hospital, Geneva

  • Valentina Belfontali, Resident · University Hospital, Geneva

  • Jordi Vidal Fortuny, SPR · University Hospital, Geneva

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02249780 on ClinicalTrials.gov